Scarica l'app Stockscreener
45.21
2.96%
1.30
Dopo l'orario di chiusura:
45.86
0.65
+1.44%
Anaptysbio Inc Azioni (ANAB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
19.83%
22.26
|
27.77 | 30.02 | 10.97 | 7.179 |
Operating Expenses
|
12.43%
48.43
|
55.31 | 52.77 | 51.29 | 49.38 |
| Benefits Costs and Expenses |
9.25%
60.85
|
67.06 | 62.87 | 57.62 | - |
| Costs And Expenses |
9.25%
60.85
|
67.06 | 62.87 | 57.62 | 49.38 |
| Operating Income/Loss |
4.97%
-26.17
|
-27.54 | -22.76 | -40.32 | -42.20 |
| Nonoperating Income/Loss |
5.75%
-12.42
|
-11.75 | -10.09 | -6.33 | -1.735 |
| Income/Loss From Continuing Operations Before Tax |
1.77%
-38.59
|
-39.28 | -32.85 | -46.65 | -43.94 |
| Income Tax Expense/Benefit |
11.36%
0.039
|
0.044 | - | 0.009 | - |
| Income/Loss From Continuing Operations After Tax |
1.78%
-38.63
|
-39.33 | -32.85 | -46.66 | -43.94 |
|
Net Income/Loss
|
1.78%
-38.63
|
-39.33 | -32.85 | -46.66 | -43.94 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.98%
28.81
|
30.64 | 28.89 | 27.36 | 26.80 |
| Diluted Average Shares |
5.98%
28.81
|
30.64 | 28.89 | 27.36 | 26.80 |
| Basic Earnings Per Share |
4.69%
-1.34
|
-1.28 | -1.14 | -1.71 | -1.64 |
| Diluted Earnings Per Share |
4.69%
-1.34
|
-1.28 | -1.14 | -1.71 | -1.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):